Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.1M Buy
116,687
+105,367
+931% +$10.1M 0.06% 373
2026
Q1
$1.17M Buy
+11,320
New +$1.28M 0.01% 1348
2025
Q4
Sell
-2,972
Closed -$366K 1179
2025
Q3
$366K Sell
2,972
-26,748
-90% -$3.32M ﹤0.01% 1530
2025
Q2
$3.57M Sell
29,720
-16,814
-36% -$2.24M 0.04% 564
2025
Q1
$6.85M Buy
46,534
+24,360
+110% +$3.72M 0.1% 284
2024
Q4
$3.6M Buy
22,174
+372
+2% +$60.9K 0.05% 485
2024
Q3
$3.55M Sell
21,802
-10,353
-32% -$1.53M 0.06% 472
2024
Q2
$4.39M Buy
32,155
+12,147
+61% +$1.69M 0.08% 365
2024
Q1
$3.06M Buy
20,008
+1,558
+8% +$233K 0.06% 456
2023
Q4
$2.63M Buy
18,450
+14,280
+342% +$1.9M 0.07% 419
2023
Q3
$547K Buy
+4,170
New +$634K 0.02% 892
2021
Q3
Sell
-1,792
Closed -$322K 217
2021
Q2
$322K Buy
+1,792
New +$327K 0.04% 200

Other funds holding CLX

Empowered Funds's CLX Position: Q2 2026 in Review

Empowered Funds increased its Clorox (CLX) stake by 931% in Q2 2026, buying an estimated $10.1M and bringing the position to 116,687 shares worth $11.1M. The position accounts for 0.06% of the portfolio, ranked #373.

Empowered Funds first reported a position in CLX in Q2 2021 and has held it in 12 quarters since. 1,044 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

  • Empowered Funds held 116,687 shares of Clorox worth $11.1M as of Q2 2026.
  • Empowered Funds bought 105,367 Clorox shares in Q2 2026, an estimated $10.1M.
  • Clorox made up 0.06% of Empowered Funds's portfolio in Q2 2026, its #373 holding.
  • Empowered Funds first reported a position in Clorox in Q2 2021 and has held it in 12 quarters since.
  • 1,044 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on Empowered Funds's 13F filing for Q2 2026, filed 17 Aug 2026.